Rethinking obstructive sleep apnoea: integrating precision medicine and technological advances across the lifespan

Obstructive sleep apnoea (OSA) has evolved from a traditionally underrecognized sleep disorder to a complex, multisystem disease with profound cardiovascular, metabolic, and neurocognitive implications. The five review articles included in this issue collectively reflect a paradigm shift in our understanding and management of OSA, highlighting the limitations of conventional approaches while emphasizing the emergence of […]

Obstructive sleep apnea in obesity: traditional and emerging treatment strategies

Introduction Obstructive sleep apnea (OSA) is a highly prevalent disorder associated with a wide range of adverse health outcomes. Obesity is one of the most well-established risk factors for OSA, and its global prevalence has continued to rise over recent decades. In the adult population, the prevalence of OSA is estimated to be around 25%; […]

Approach to obstructive sleep apnea in children from a cardiovascular perspective

Introduction Exposure to risk factors during childhood may contribute to the development of future cardiovascular (CV) disease. Thus, obstructive sleep apnea (OSA) could act as a precipitating factor and be a modifiable risk factor. The use of new imaging tools, such as echocardiography, or the incorporation of new biological signals extracted from sleep studies or […]

New bio signals in sleep studies scoring

Introduction Obstructive sleep apnea (OSA) is a common sleep disorder affecting up to 1 billion adults worldwide1. Repetitive upper airway obstructions characterize OSA during sleep, leading to acute physiological changes, including intermittent nocturnal hypoxemia, sympathetic activation, intrathoracic pressure changes, arousals, and sleep fragmentation2–4. Furthermore, the nightly occurrence of these acute downstream effects of airway obstruction […]

Artificial intelligence applied to sleep medicine

Obstructive sleep apnea (OSA) is the most common sleep-disordered breathing disorder, with a variable prevalence ranging from 4% to 30% depending on the environment1,2. OSA induces intermittent hypoxia, sleep fragmentation, and changes in intrathoracic pressure that promote the development of cardiovascular disease, arrhythmias, ischemic heart disease, hypertension (HTN), pulmonary thromboembolism, pulmonary HTN, heart failure, diabetes […]